# Reverse Genetic H9N2 Influenza Vaccine Study in Adults

> **NCT01320696** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alachua Government Services, Inc.** · enrollment: 353 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine

## Key facts

- **NCT ID:** NCT01320696
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-06
- **Final completion:** 2012-05
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320696, "Reverse Genetic H9N2 Influenza Vaccine Study in Adults". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01320696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*